Non-integrin laminin receptors in epithelia.


Journal

Tissue & cell
ISSN: 1532-3072
Titre abrégé: Tissue Cell
Pays: Scotland
ID NLM: 0214745

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 10 10 2018
revised: 17 12 2018
accepted: 21 12 2018
entrez: 10 2 2019
pubmed: 10 2 2019
medline: 23 2 2019
Statut: ppublish

Résumé

The interactions between cells and the extracellular matrix (ECM) play a major role in normal and pathological conditions. The ECM can modulate several biological functions including cell proliferation, adhesion, differentiation and survival through its interactions with cell receptors. Laminins are one of the most important glycoproteins present in basement membranes, a type of ECM. The pattern of expression of its different isoforms depends on the spatiotemporal organization of each tissue. While integrins are the most studied laminin receptors, other non-integrin laminin receptors are also involved. This review focuses on two particular non-integrin laminin receptors in the epithelial context: dystroglycan and 37/67 laminin receptor (37/67LR). Dystroglycan is a two-subunit protein discovered in the muscle as part of the dystrophin-associated glycoprotein complex. This protein can also be found in many epithelia where its roles are variable. The 37/67LR is a still incompletely understood laminin receptor that is important to regulate intestinal epithelial cell function and could be involved in various pathological conditions.

Identifiants

pubmed: 30736907
pii: S0040-8166(18)30366-5
doi: 10.1016/j.tice.2018.12.005
pii:
doi:

Substances chimiques

Integrins 0
Laminin 0
Receptors, Laminin 0
Dystroglycans 146888-27-9

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

71-78

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Gabriel Cloutier (G)

Laboratory of Intestinal Physiopathology, Department of Anatomy & Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, J1H 5N4, Canada. Electronic address: Gabriel.Cloutier3@USherbrooke.ca.

Amélie Sallenbach-Morrissette (A)

Laboratory of Intestinal Physiopathology, Department of Anatomy & Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, J1H 5N4, Canada. Electronic address: Amelie.Sallenbach-Morrissette@USherbrooke.ca.

Jean-François Beaulieu (JF)

Laboratory of Intestinal Physiopathology, Department of Anatomy & Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, J1H 5N4, Canada. Electronic address: Jean-Francois.Beaulieu@USherbrooke.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH